Alice Y Y Cheng (Alice Cheng)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Glycemic Control

Decision Making

Health Promotion

Top Venues

Nature reviews. Endocrinology

Diabetes therapy : research, treatment and education of diabetes and related disorders

Diabetes/metabolism research and reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Alice Y Y Cheng, Marília Brito Gomes, Sanjay Kalra, Andre Pascal Kengne, Chantal Mathieu, Jonathan Edward Shaw
Applying the WHO global targets for diabetes mellitus. Nature reviews. Endocrinology 19 (4) (2023)
Naresh Kanumilli, Javed Butler, Konstantinos Makrilakis, Lars Rydén, Michael Vallis, Christoph Wanner, Shelley Zieroth, Ahmad Alhussein, Alice Y Y Cheng
Guardians For Health: A Practical Approach to Improving Quality of Life and Longevity in People with Type 2 Diabetes. Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Kamlesh Khunti F MedSci, Alice Y Y Cheng
Therapeutic inertia in type 2 diabetes mellitus: a fine line between advancing and de-intensifying. Nature reviews. Endocrinology (2023)
Alice Y Y Cheng, Marília Brito Gomes, Sanjay Kalra, Andre Pascal Kengne, Chantal Mathieu, Jonathan Edward Shaw
Applying the WHO global targets for diabetes mellitus. Nature reviews. Endocrinology 19 (4) (2023)
Christophe E M De Block, Alice Y Y Cheng, Trine Brandt Christensen, Usha Rani H Patted, Anna Ginovker
Healthcare Professionals' Knowledge of and Attitudes Towards the Use of Time in Range in Diabetes Management: Online Survey Across Seven Countries. Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Alice Y Y Cheng, Marília Brito Gomes, Sanjay Kalra, Andre Pascal Kengne, Chantal Mathieu, Jonathan Edward Shaw
Applying the WHO global targets for diabetes mellitus. Nature reviews. Endocrinology (2023)
Ronald M Goldenberg, Alice Y Y Cheng, Tess Fitzpatrick, Jeremy D Gilbert, Subodh Verma, Julia J Hopyan
Benefits of GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists for Stroke Reduction in Type 2 Diabetes: A Call to Action for Neurologists. Stroke 53 (5) (2022)
Alice Y Y Cheng, Jencia Wong, Nick Freemantle, Shamasunder H Acharya, Elif Ekinci
The Safety and Efficacy of Second-Generation Basal Insulin Analogues in Adults with Type 2 Diabetes at Risk of Hypoglycemia and Use in Other Special Populations: A Narrative Review. Diabetes therapy : research, treatment and education of diabetes and related disorders 11 (11) (2020)
Alice Y Y Cheng, Timothy S Bailey, Esmeralda Castelblanco, Ronan Roussel
Insulin glargine 300 U/mL and insulin degludec: A review of the current evidence comparing these two second-generation basal insulin analogues. Diabetes/metabolism research and reviews (2020)
Alice Y Y Cheng, Dhiren K Patel, Timothy S Reid, Kathleen Wyne
Differentiating Basal Insulin Preparations: Understanding How They Work Explains Why They Are Different. Advances in therapy 36 (5) (2019)
Alice Y Y Cheng, Stewart Harris, Francesco Giorgino, Jochen Seufert, Robert Ritzel, Kamlesh Khunti F MedSci, Felipe Lauand, Lydie Melas-Melt, Jukka Westerbacka, Zsolt Bosnyak, Julio Rosenstock
Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study. Diabetes, obesity & metabolism 22 (3) (2019)